Management of Sodium 129 mmol/L in Patient on Coversyl Plus
Stop Coversyl Plus immediately and check renal function urgently - this sodium level of 129 mmol/L represents moderate hyponatremia that falls in the critical 121-125 mmol/L range where ACE inhibitor-diuretic combinations commonly cause drug-induced hyponatremia requiring medication discontinuation.
Immediate Actions
Discontinue Coversyl Plus - The combination of perindopril (ACE inhibitor) and indapamide (thiazide-like diuretic) is a well-established cause of hyponatremia 1. Indapamide specifically can cause severe hyponatremia with onset as early as 2 weeks after initiation, with documented cases dropping sodium to 110-116 mEq/L 2.
Check serum creatinine immediately - This determines your next management step:
If creatinine is normal (<120 μmol/L): Observe closely with serial electrolytes. Do NOT water restrict 3.
If creatinine is elevated (>150 μmol/L or >120 μmol/L and rising): Give volume expansion with colloid (gelofusine, haemaccel, voluven) or normal saline 3.
Key Management Principles
Avoid water restriction - Despite being common practice, water restriction is likely counterproductive as it may worsen effective hypovolaemia, driving further ADH secretion and potentially worsening renal function 3. The pathophysiology suggests plasma expansion is more logical than fluid restriction.
Monitor sodium correction rate - When correcting, avoid increasing serum sodium by >12 mmol/L per 24 hours to prevent central pontine myelinolysis 3.
Assess for symptoms - Look for anorexia, fatigue, nausea, confusion, or altered mental status. Even with preserved consciousness, symptoms may be subtle 2.
Alternative Antihypertensive Strategy
Once sodium normalizes, consider switching to:
Perindopril + amlodipine (without the indapamide component) - This combination provides effective BP control without the thiazide-like diuretic that caused hyponatremia 4, 5. Amlodipine does not cause hyponatremia and may actually cause mild natriuresis 6.
Monitor electrolytes weekly for the first month after any medication change, then monthly for 3 months.
Common Pitfalls to Avoid
- Don't continue the medication "just to observe" - At sodium 129 mmol/L with recent drug initiation, this is drug-induced until proven otherwise
- Don't assume it's dilutional - Thiazide-like diuretics cause true sodium depletion
- Don't water restrict - This worsens the underlying pathophysiology
- Don't correct too rapidly - Risk of osmotic demyelination syndrome
Follow-up Timeline
- Days 1-3: Daily sodium checks until stable upward trend
- Day 6-7: Should see improvement toward 130 mmol/L if drug-induced 2
- Week 2: Recheck before considering alternative antihypertensive
- Month 1: If restarting BP medication, weekly sodium monitoring
The evidence strongly supports that this is indapamide-induced hyponatremia requiring immediate discontinuation, with the ACE inhibitor component potentially contributing through RAAS effects on sodium handling.